tizanidin orion 2 mg tabletta
orion corporation - tizanidin -
tizanidin orion 4 mg tabletta
orion corporation - tizanidin -
sirdalud 4 mg tabletta
sandoz hungária kft. - tizanidin -
sirdalud mr 6 mg retard kapszula
sandoz hungária kft. - tizanidin -
sirdalud 2 mg tabletta
novartis hungária kft. pharma részlege - tizanidin -
sirdalud 4 mg tabletta
novartis hungária kft. pharma részlege - tizanidin -
tizagelan 2 mg tabletta
g.l. pharma gmbh - tizanidin -
tizagelan 4 mg tabletta
g.l. pharma gmbh - tizanidin -
jangee flexibilis 3 mg/0,02 mg filmtabletta
exeltis kft. - drospirenone; ethinylestradiol -
tabrecta
novartis europharm limited - capmatinib dihydrochloride monohydrate - karcinóma, nem kissejtes tüdő - daganatellenes szerek - tabrecta as monotherapy is indicated for the treatment of adult patients with advanced non small cell lung cancer (nsclc) harbouring alterations leading to mesenchymal epithelial transition factor gene exon 14 (metex14) skipping, who require systemic therapy following prior treatment with immunotherapy and/or platinum based chemotherapy.